SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 30th, 2021 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • New York
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of February 5, 2021, is between AnPac Bio-Medical Science Co., Ltd., a company incorporated under the laws of the British Virgin Islands, with headquarter located at 801 Bixing Street, Bihu County, Lishui, Zhejiang Province 323006, People’s Republic of China (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively the “Buyers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 30th, 2021 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • New York
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 5, 2021, by and among AnPac Bio-Medical Science Co., Ltd. a British Virgin Islands corporation (the “Company”), and investors identified on the signatory pages to this Agreement (the “Investors”).
Dr. Chris Yu Chairman AnPac Bio-Medical Science Co., Ltd.. Dear Dr. Yu,AnPac Bio-Medical Science Co., Ltd. • April 30th, 2021 • Services-medical laboratories • New York
This letter (the “Agreement”) constitutes the agreement between Univest Securities, LLC (“Univest”), or the (“Placement Agent/(s)”) and AnPac Bio-Medical Science Co., Ltd.., a company incorporated under the laws in the Cayman Island (the “Company”), pursuant to which the Placement Agent shall serve as the exclusive placement agent of public offerings for the Company, on a “reasonable best efforts”, timely and effective basis, in connection with the proposed placement (the “Placement”) of securities and instruments, including Class A ordinary shares being represented by American depositary shares (ADSs), being registered within Company’s shelf registration statement to be on Form F-3(and F1 relating to or required for public offerings) (collectively the “Securities”), with the intention to conduct an raise sizing around $15,000,000. Univest shall use its best efforts to complete the Placement as soon as practical but no later than the Termination Date (as defined below) set forth herein
